Skip to content
MarketScale
‹ Back to IndustriesHealthcare

AI-Powered Remote Cardiac Monitoring Improves Care Access, Disease Detection, and Diagnostic Accuracy

AI-powered remote cardiac monitoring technology from InfoBionic.AI is transforming cardiovascular care by enabling continuous, near real-time detection of arrhythmias and reducing false positives for atrial fibrillation by over 85%. The platform leverages algorithms developed in collaboration with Mayo Clinic and streams data to the cloud for physician review. It also improves health equity by eliminating the need for in-person visits, expanding care access to rural and underserved populations.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

By Kevin Stevenson · Ai-powered Cardiac MonitoringCardiovascular Disease DetectionI Don't Care PodcastInfobionic.ai
Share

Key takeaways

01

InfoBionic.AI's AI platform reduces false positives for atrial fibrillation by over 85%, delivering cleaner diagnostic data to clinicians.

02

Continuous cloud-based monitoring processes millions of heartbeats in near real-time, prioritizing critical information for physicians.

03

Remote cardiac monitoring removes barriers to in-person visits, improving care access for patients in rural and underserved areas.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Advancements in artificial intelligence are transforming healthcare, and remote cardiac monitoring is at the forefront of this change. With cardiovascular disease impacting nearly 50% of the population at some point in their lives, early detection and efficient diagnosis are crucial. Enter AI-powered cardiac monitors that provide near real-time data, reduce diagnostic errors, and improve access to care. But how exactly does this technology work, and what does it mean for patients and healthcare providers?

Welcome to I Don't Care. In this episode, Dr Kevin Stevenson sits down with Stuart Long, the CEO of InfoBionic.AI, to explore the transformative impact of AI on cardiac monitoring. From continuous monitoring that detects arrhythmias in real-time to algorithms developed in collaboration with Mayo Clinic, this conversation addresses a vital question: How can technology redefine the landscape of cardiac care?

Key Points of Discussion:

  • Continuous Monitoring Revolution: InfoBionic's device streams data to the cloud, using AI to process millions of heartbeats and prioritize critical information for physicians.
  • Reducing False Positives: By leveraging advanced AI and signal processing, the company has reduced false positives for atrial fibrillation by over 85%, providing clinicians with cleaner, more actionable data. By leveraging advanced AI and signal processing, the company has reduced false positives for atrial fibrillation by over 85%, providing clinicians with cleaner, more actionable data.
  • Improving Health Equity: With remote cardiac monitoring solutions that eliminate the need for in-person visits, InfoBionic ensures greater access to cardiac care, especially in rural areas.

Stuart Long is a seasoned healthcare executive with over 30 years of experience leading and scaling companies in the medical device and healthcare IT sectors. As CEO of InfoBionic.AI, he has pioneered advancements in AI-powered cardiac monitoring, significantly improving diagnostic accuracy and patient outcomes. With expertise in enterprise software, medical imaging, and strategic operations, Long also brings a strong background in marketing strategy, honed at Cornell University's Johnson Graduate School of Management.

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

Kevin Stevenson
Kevin StevensonTop Hospital Administrator & Healthcare COO, I Don't Care

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

AI is compressing drug discovery timelines from years to months, and clinical operators need to prepare now

AI is compressing drug discovery timelines from years to months, and clinical operators need to prepare now

Generative AI is accelerating drug discovery processes, significantly reducing timelines from years to mere months. Clinical operators must adapt to this rapid change as AI-designed solutions become integral to the healthcare pipeline.

  • 01Generative AI is capable of reducing drug discovery timelines from years to months.
  • 02The integration of AI into healthcare is necessitating changes in clinical operations.
  • 03AI-informed patients are becoming more common in clinical settings.

Aug 12, 2026

Siemens Healthineers and Cleveland Clinic sign a 10-year alliance as ambient AI reshapes the EHR debate

Siemens Healthineers and Cleveland Clinic sign a 10-year alliance as ambient AI reshapes the EHR debate

Siemens Healthineers and Cleveland Clinic have entered into a 10-year alliance focusing on ambient AI and its integration into electronic health records (EHR). This partnership aims to enhance healthcare delivery systems and streamline clinical processes through advanced technology.

  • 01Siemens Healthineers and Cleveland Clinic have formed a 10-year partnership to explore ambient AI in healthcare.
  • 02The alliance focuses on transforming electronic health records (EHR) with the integration of new AI technologies.
  • 03The partnership aims to improve healthcare delivery and streamline clinical processes.

Aug 9, 2026

A Physician Entrepreneur's Journey in Specialty Care Expansion - Dr. Joe Pazona, CEO of VirtuCare

Dr. Joe Pazona shares insights into his journey as a physician entrepreneur focusing on specialty care expansion. He highlights the challenges and strategies involved in growing a healthcare business. The discussion offers valuable lessons for other healthcare professionals looking to innovate and expand in their practices.

  • 01A physician entrepreneur focuses on specialty care expansion.
  • 02Innovative strategies are necessary for growth in healthcare businesses.
  • 03Lessons from healthcare leaders can help others in the industry.

Aug 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

Kevin Stevenson
Kevin Stevenson

Host, I Don't Care Podcast

I Don't Care

Kevin Stevenson is the host of the I Don't Care podcast on MarketScale, focused on the challenges facing healthcare executives and administrators. He engages with industry leaders who support hospitals, urgent care centers, and telemedicine operators. Stevenson holds a DHA and FACHE designation, reflecting his background in healthcare administration.

SL
Stuart Long

CEO

InfoBionic.AI

Stuart Long is a healthcare executive with over 30 years of experience leading and scaling companies in the medical device and healthcare IT sectors. As CEO of InfoBionic.AI, he has driven advancements in AI-powered cardiac monitoring to improve diagnostic accuracy and patient outcomes. He holds a background in marketing strategy from Cornell University's Johnson Graduate School of Management.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512